Increased incidence of head and neck cancer in liver transplant recipients: A meta-analysis

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Liu, Qian ^a,b   Yan, Lifeng ^a,b   Xu, Cheng ^a,b   Gu, Aihua ^a,b   Zhao, Peng ^a   Jiang, Zhao Yan ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Head and neck cancer; Liver transplantation; Meta analysis; Standardized incidence ratio

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; FOLLOW UP; GRAFT RECIPIENT; HEAD AND NECK CANCER; HUMAN; LIVER TRANSPLANTATION; POPULATION RISK; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADVERSE EFFECTS; HEAD AND NECK NEOPLASMS; INCIDENCE; META ANALYSIS; PUBLISHING; RISK;

HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; ODDS RATIO; PUBLICATION BIAS; TRANSPLANT RECIPIENTS;

EID: 84929942342     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-776     Document Type: Article

References (46)

1. The American Association for the Study of Liver Diseases: National Institutes of Health Consensus Development Conference Statement: liver transplantation-June 20-23, 1983. Hepatology 1984, 4(1 Suppl):107S-110S.
2. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M: Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011, 306(17):1891-1901.
3. Karamchandani D, Arias-Amaya R, Donaldson N, Gilbert J, Schulte KM: Thyroid cancer and renal transplantation: a meta-analysis. Endocr Relat Cancer 2010, 17(1):159-167.
4. Rabinovics N, Mizrachi A, Hadar T, Ad-El D, Feinmesser R, Guttman D, Shpitzer T, Bachar G: Cancer of the head and neck region in solid organ transplant recipients. Head Neck 2014, 36(2):181-186.
5. Grulich AE, Van Leeuwen MT, Falster MO, Vajdic CM: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370(9581):59-67.
6. Sint Nicolaas J, De Jonge V, Steyerberg EW, Kuipers EJ, Van Leerdam ME, Veldhuyzen-van Zanten SJ: Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010, 10(4):868-876.
7. Gourin CG, Terris DJ: Head and neck cancer in transplant recipients. Curr Opin Otolaryngol Head Neck Surg 2004, 12(2):122-126.
8. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B: De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001, 7(11 Suppl 1):S109-S118.
9. Ramsay HM, Reece SM, Fryer AA, Smith AG, Harden PN: Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients. Transplantation 2007, 84(3):437-439.
10. Jimenez C, Lumbreras C, Paseiro G, Loinaz C, Romano DR, Andres A, Aguado JM, Morales JM, Del Palacio A, Garcia I, Moreno E: Treatment of mucor infection after liver or pancreas-kidney transplantation. Transplant Proc 2002, 34(1):82-83.
11. Frezza EE, Fung JJ, Van Thiel DH: Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997, 44(16):1172-1181.
12. Tallon Aguilar L, Barrera Pulido L, Bernal Bellido C, Pareja Ciuro F, Suarez Artacho G, Alamo Martinez JM, Garcia Gonzalez I, Gomez Bravo MA, Bernardos Rodriguez A: Causes and predisposing factors of de novo tumors in our series of liver transplant recipients. Transplant Proc 2009, 41(6):2453-2454.
13. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J: Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002, 8(5):482-487.
14. Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB: De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002, 8(3):285-291.
15. Duvoux C, Delacroix I, Richardet JP, Roudot-Thoraval F, Metreau JM, Fagniez PL, Dhumeaux D, Cherqui D: Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999, 67(3):418-421.
16. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ: Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998, 66(9):1193-1200.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
18. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
19. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, Sforza D, Miglioresi L, Fantola G, Cimaglia C, Vennarecci G, Vizzini GB, Di Leo A, Rossi M, Tisone G, Zamboni F, Santoro R, Agresta A, Puro V, Serraino D: De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc 2013, 45(7):2729-2732.
20. Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N: De novo malignancies after adult-to-adult livingdonor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation 2013, 95(9):1142-1147.
21. Krynitz B, Edgren G, Lindelof B, Baecklund E, Brattstrom C, Wilczek H, Smedby KE: Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2013, 132(6):1429-1438.
22. Herrero JI, Pardo F, D'Avola D, Alegre F, Rotellar F, Inarrairaegui M, Marti P, Sangro B, Quiroga J: Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal. Liver Transpl 2011, 17(4):402-408.
23. Collett D, Mumford L, Banner NR, Neuberger J, Watson C: Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010, 10(8):1889-1896.
24. Herrero JI, Alegre F, Quiroga J, Pardo F, Inarrairaegui M, Sangro B, Rotellar F, Montiel C, Prieto J: Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009, 23(4):532-536.
25. Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, Gambato M, Buda A, Zanus G, Vitale A, De Paoli A, Cimaglia C, Bresadola V, Toniutto P, Risaliti A, Cillo U, Bresadola F, Burra P: Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis 2010, 42(1):55-60.
26. Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y: Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl 2008, 14(11):1588-1597.
27. Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H: Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008, 14(10):1428-1436.
28. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S, Immunosuppression and Cancer Study Group: Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007, 43(14):2117-2123.
29. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, De Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL: Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001, 34(1):84-91.
30. Chak E, Saab S: Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int 2010, 30(9):1247-1258.
31. Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T: Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001, 27(4):409-413.
32. Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Masetti M, Montalti R, Ballarin R, Cocchi S, Potenza L, Luppi M, Gerunda GE: Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008, 134(6):653-658.
33. Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J: Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol 2007, 80(953):337-346.
34. Sheil AG: Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. Br Med J 1984, 288(6418):659-661.
35. Penn I: Why do immunosuppressed patients develop cancer? Crit Rev Oncog 1989, 1(1):27-52.
36. Dalton A, Curtis D, Harrington CI: Synergistic effects of azathioprine and ultraviolet light detected by sister chromatid exchange analysis. Cancer Genet Cytogenet 1990, 45(1):93-99.
37. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397(6719):530-534.
38. Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayon M, Mir J, Segura A, Berenguer J: De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004, 4(4):596-604.
39. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J: Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000, 70(9):1335-1342.
40. Jimenez C, Rodriguez D, Marques E, Loinaz C, Alonso O, Hernandez-Vallejo G, Marin L, Rodriguez F, Garcia I, Moreno E: De novo tumors after orthotopic liver transplantation. Transplant Proc 2002, 34(1):297-298.
41. La Vecchia C, Zhang ZF, Altieri A: Alcohol and laryngeal cancer: an update. Eur J Cancer Prev 2008, 17(2):116-124.
42. Vallejo GH, Romero CJ, De Vicente JC: Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005, 56(1):87-99.
43. DiMartini A, Javed L, Russell S, Dew MA, Fitzgerald MG, Jain A, Fung J: Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl 2005, 11(6):679-683.
44. Nelissen C, Lambrecht M, Nevens F, Van Raemdonck D, Vanhaecke J, Kuypers D, Pirenne J, Nuyts S: Noncutaneous head and neck cancer in solid organ transplant patients: single center experience. Oral Oncol 2014, 50(4):263-268.
45. Harper RG, Wager J, Chacko RC: Psychosocial factors in noncompliance during liver transplant selection. J Clin Psychol Med Settings 2010, 17(1):71-76.
46. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP: Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998, 351(9103):623-628.